Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Equity Ratio (2016 - 2025)

Assembly Biosciences has reported Equity Ratio over the past 11 years, most recently at 0.8 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.8 for Q4 2025, up 186.72% from a year ago — trailing twelve months through Dec 2025 was 0.8 (up 186.72% YoY), and the annual figure for FY2025 was 0.8, up 186.72%.
  • Equity Ratio for Q4 2025 was 0.8 at Assembly Biosciences, up from 0.76 in the prior quarter.
  • Over the last five years, Equity Ratio for ASMB hit a ceiling of 0.9 in Q3 2021 and a floor of 0.22 in Q2 2025.
  • Median Equity Ratio over the past 5 years was 0.81 (2022), compared with a mean of 0.65.
  • Biggest five-year swings in Equity Ratio: plummeted 67.9% in 2024 and later skyrocketed 193.52% in 2025.
  • Assembly Biosciences' Equity Ratio stood at 0.88 in 2021, then dropped by 8.15% to 0.81 in 2022, then plummeted by 63.01% to 0.3 in 2023, then decreased by 6.8% to 0.28 in 2024, then skyrocketed by 186.72% to 0.8 in 2025.
  • The last three reported values for Equity Ratio were 0.8 (Q4 2025), 0.76 (Q3 2025), and 0.22 (Q2 2025) per Business Quant data.